The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective
Open accessAbstract
The blood–brain barrier (BBB) is a critical biological structure that prevents damage to the brain and maintains its bathing microenvironment. However, this barrier is also the obstacle to deliver beneficial drugs to treat CNS (central nervous system) diseases. Many efforts have been made for improvement of delivering drugs across the BBB in recent years to treat CNS diseases. In this review, the anatomical and functional structure of the BBB is comprehensively discussed. The mechanisms of BBB penetration are summarized, and the methods and effects on increasing BBB permeability are investigated in detail. It also elaborates on the physical, chemical, biological and nanocarrier aspects to improve drug delivery penetration to the brain and introduces some specific drug delivery effects on BBB permeability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Aerosols implicated as a prime driver of twentieth-century North Atlantic climate variability
Booth, B. B. B., Dunstone, N. J., Halloran, P. R., Andrews, T., & Bellouin, N. (2012) · Nature · doi:10.1038/nature10946 · Cited by 1,022
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 960
Blood–brain barrier structure and function and the challenges for CNS drug delivery
Abbott, N. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9608-0 · Cited by 909
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
Wood, I. S., & Trayhurn, P. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002763 · Cited by 889
Structure−Brain Exposure Relationships
Hitchcock, S. A., & Pennington, L. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060642i · Cited by 698
Al-Jamal, W. T., & Kostarelos, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200105p · Cited by 696
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
P-glycoprotein Inhibition for Optimal Drug Delivery
Amin, M. L. (2013) · Drug Target Insights · doi:10.4137/dti.s12519 · Cited by 624
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 528
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Aryal, M., Arvanitis, C. D., Alexander, P. M., & McDannold, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.008 · Cited by 443
Drug delivery to the central nervous system: a review.
Misra, A. R., Ganesh, S. D., Shahiwala, A., & Shah, S. P. (2003) · PubMed · Cited by 441
Liu, H.-L., Hua, M.-Y., Yang, H.-W., Huang, C.-Y., Chu, P.-C., Wu, J.-S., Tseng, I.-C., Wang, J.-J., Yen, T.-C., Chen, P.-Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003388107 · Cited by 395
Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism
Lundgaard, I., Li, B., Xie, L., Kang, H., Sanggaard, S., Haswell, J. D. R., Sun, W., Goldman, S., Blekot, S., Nielsen, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7807 · Cited by 381
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363
Loureiro, J., Andrade, S., Duarte, A., Neves, A., Queiroz, J., Nunes, C., Sevin, E., Fenart, L., Gosselet, F., Coelho, M., et al. (2017) · Molecules · doi:10.3390/molecules22020277 · Cited by 341
Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood–Brain Barrier
Qiao, R., Jia, Q., Hüwel, S., Xia, R., Liu, T., Gao, F., Galla, H.-J., & Gao, M. (2012) · ACS Nano · doi:10.1021/nn300240p · Cited by 326
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Focused ultrasound-mediated drug delivery through the blood–brain barrier
Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 323
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., & Sheikov, N. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.105.3.445 · Cited by 314
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
Weaver, M., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 299
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
McDannold, N., Vykhodtseva, N., & Hynynen, K. (2008) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.10.016 · Cited by 288
Das, S., Ng, W. K., Kanaujia, P., Kim, S., & Tan, R. B. H. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.07.036 · Cited by 274
Preparation and brain delivery property of biodegradable polymersomes conjugated with ox26
Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., Gao, X., Jiang, X., & Zhu, C. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.007 · Cited by 264
Bicker, J., Alves, G., Fortuna, A., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.012 · Cited by 262
Nasal Drug Administration: Potential for Targeted Central Nervous System Delivery
Graff, C. L., & Pollack, G. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20318 · Cited by 260
Gut reactions: how the blood-brain barrier connects the microbiome and the brain
Logsdon, A. F., Erickson, M. A., Rhea, E. M., Salameh, T. S., & Banks, W. A. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217743766 · Cited by 235
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Magnetic targeting of nanoparticles across the intact blood–brain barrier
Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226
Overview of P-glycoprotein inhibitors: a rational outlook
Srivalli, K. M. R., & Lakshmi, P. K. (2012) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502012000300002 · Cited by 225
Shityakov, S., & Foerster, C. (2014) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s63749 · Cited by 225
Georgieva, J., Hoekstra, D., & Zuhorn, I. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6040557 · Cited by 211
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
Gaillard, P. J., Appeldoorn, C. C. M., Rip, J., Dorland, R., van der Pol, S. M. A., Kooij, G., de Vries, H. E., & Reijerkerk, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.022 · Cited by 191
Hanada, S., Fujioka, K., Inoue, Y., Kanaya, F., Manome, Y., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15021812 · Cited by 186
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Bellavance, M.-A., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 184
Prodrug Approaches for CNS Delivery
Rautio, J., Laine, K., Gynther, M., & Savolainen, J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9009-8 · Cited by 176
Lembo, D., Donalisio, M., Civra, A., Argenziano, M., & Cavalli, R. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1360863 · Cited by 174
Widera, A., Norouziyan, F., & Shen, W.-C. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.004 · Cited by 173
Polat, B. E., Blankschtein, D., & Langer, R. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538679 · Cited by 164
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Zou, L.-L., Ma, J.-L., Wang, T., Yang, T.-B., & Liu, C.-B. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020006 · Cited by 163
Wohlfart, S., Khalansky, A. S., Gelperina, S., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162
Tabatabaei, S. N., Girouard, H., Carret, A., & Martel, S. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.027 · Cited by 160
Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160
Penetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 160
Self-citationPEGylation and polyPEGylation of nanodiamond
Zhang, X., Fu, C., Feng, L., Ji, Y. J., Tao, L., Huang, Q., Li, S., & Wei, Y. (2012) · Polymer · doi:10.1016/j.polymer.2012.05.029 · Cited by 152
Johnsen, K. B., & Moos, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.032 · Cited by 147
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods
Schuster, B. S., Ensign, L. M., Allan, D., Suk, J. S., & Hanes, J. S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.017 · Cited by 141
LSR/angulin-1 is a tricellular tight junction protein involved in blood–brain barrier formation
Sohet, F., Lin, C., Munji, R. N., Lee, S. Y., Ruderisch, N., Soung, A., Arnold, T. D., Derugin, N., Vexler, Z. S., Yen, F. T., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410131 · Cited by 139
Protein components of the blood–brain barrier (BBB) in the mediobasal hypothalamus
Gregory, E. N., Gömüç, B., & Meister, B. (2008) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2008.06.002 · Cited by 138
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery
Chen, H., Tang, L., Qin, Y., Yin, Y., Tang, J., Tang, W., Sun, X., Zhang, Z., Liu, J., & He, Q. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.007 · Cited by 132
Self-citationShevtsov, M. A., Nikolaev, B. P., Yakovleva, L. Y., Marchenko, Y., Михрина, А. Л., Martynova, M. G., Bystrova, O. A., Добродумов, А. В., Ischenko, A. M., & Yakovenko, I. V. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55118 · Cited by 132
Nanoparticle‐Based Therapeutics for Brain Injury
Bharadwaj, V. N., Nguyen, D. T., Kodibagkar, V. D., & Stabenfeldt, S. E. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700668 · Cited by 130
D’Agata, F., Ruffinatti, F. A., Boschi, S., Stura, I., Rainero, I., Abollino, O., Cavalli, R., & Guiot, C. (2017) · Molecules · doi:10.3390/molecules23010009 · Cited by 130
Therapeutic strategies to improve drug delivery across the blood-brain barrier
Azad, T. D., Pan, J., Connolly, I. D., Remington, A. C., Wilson, C., & Grant, G. A. (2015) · Neurosurgical FOCUS · doi:10.3171/2014.12.focus14758 · Cited by 127
Recent Patents Review on Intranasal Administration for CNS Drug Delivery
Misra, A. R., Jogani, V. V., Jinturkar, K., & Vyas, T. K. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108783331429 · Cited by 112
Aryal, M., Park, J., Vykhodtseva, N. I., Zhang, Y., & McDannold, N. J. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/6/2511 · Cited by 108
Foley, C. P., Rubin, D. G., Santillán, A., Sondhi, D., Dyke, J. P., Gobin, Y. P., Crystal, R. G., & Ballon, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.018 · Cited by 97
Dyrna, F. G. E., Hanske, S., Krueger, M. C., & Bechmann, I. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9473-5 · Cited by 95
Bauer, M., Karch, R., Zeitlinger, M. A., Philippe, C., Römermann, K., Stanek, J., Maier‐Salamon, A., Wadsak, W., Jäger, W. R., Hacker, M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.19 · Cited by 93
Wang, H., Zhang, S., Liao, Z., Wang, C., Liu, Y., Feng, S., Jiang, X., & Chang, J. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.057 · Cited by 87
Recent Advances in Delivery Through the Blood-Brain Barrier
Larsen, J., Martin, D. R., & Byrne, M. E. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329230311 · Cited by 87
Wu, S.-Y., Chen, C., Tung, Y., Olumolade, O., & Konofagou, E. E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.007 · Cited by 83
Shityakov, S., Pastorin, G., Foerster, C. Y., & Salvador, E. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68429 · Cited by 80
Negishi, Y., Yamane, M., Kurihara, N., Endo‐Takahashi, Y., Sashida, S., Takagi, N., Suzuki, R., & Maruyama, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030344 · Cited by 68
Namanja-Magliano, H. A., Emmert, D., Davis, D. A., Campos, C. R., Miller, D. S., Hrycyna, C. A., & Chmielewski, J. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206867t · Cited by 62
Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy
Do, D., D'Souza, Enriquez, & Rizvi (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43479 · Cited by 60
Strategies To Target Kyotorphin Analogues to the Brain
Chen, P., Bodor, N. S., Wu, W., & Prókai, L. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970715l · Cited by 60
Tournier, N., Goutal, S., Auvity, S., Traxl, A., Mairinger, S., Wanek, T., Helal, O. B., Buvat, I., Soussan, M., Caillé, F., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178665 · Cited by 57
Jampílek, J., Záruba, К., Oravec, M., Kuneš, M., Babula, P., Ulbrich, P., Brezániová, I., Opatřilová, R., Třı́ska, J., & Suchý, P. (2015) · BioMed Research International · doi:10.1155/2015/812673 · Cited by 56
Zhang, L., Han, L., Qin, J., Lu, W., & Wang, J. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1055-y · Cited by 56
Yin, Y., Cao, L., Ge, H., Duanmu, W., Tan, L., Yuan, J., Tunan, C., Li, F., Hu, R., Gao, F., et al. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000792 · Cited by 55
Blood–brain barrier: An impediment to neuropharmaceuticals
Henderson, J., & Piquette‐Miller, M. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.77 · Cited by 54
Sancini, G. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000171 · Cited by 53
Chen, W., Yang, J. Z., Andersen, R., Nielsen, L. H., & Borchardt, R. T. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037143 · Cited by 51
Patel, R. B., Patel, M. R., Bhatt, K. K., Patel, B. G., & Gaikwad, R. V. (2014) · Drug Delivery · doi:10.3109/10717544.2014.908980 · Cited by 50
Breaching the Blood-Brain Barrier for Drug Delivery
Bell, R. D., & Ehlers, M. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.023 · Cited by 48
Enhanced brain drug delivery: safely crossing the blood–brain barrier
Gaillard, P. J., Visser, C. C., Appeldoorn, C. C. M., & Rip, J. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.12.002 · Cited by 48
Chen, T., Fonseca, C. D., & Schönthal, A. H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091463 · Cited by 47
A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model
Neves-Coelho, S., Eleutério, R. P., Enguita, F. J., Neves, V., & Castanho, M. A. R. B. (2017) · Molecules · doi:10.3390/molecules22101753 · Cited by 46
Intranasal delivery: circumventing the iron curtain to treat neurological disorders
Jiang, Y., Li, Y., & Liu, X. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1065812 · Cited by 45
Self-citationKim, H. C., Al‐Mahrouki, A., Gorjizadeh, A., Karshafian, R., & Czarnota, G. J. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.01.012 · Cited by 44
Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0120-6 · Cited by 35
Sato, Y., Sakurai, Y., Kajimoto, K., Nakamura, T., Yamada, Y., Akita, H., & Harashima, H. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600179 · Cited by 33
Vlieghe, P., & Khrestchatisky, M. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.44 · Cited by 31
Okuma, Y., Wang, F., Toyoshima, A., Kameda, M., Hishikawa, T., Tokunaga, K., Sugiu, K., Liu, K., Haruma, J., Nishibori, M., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.058 · Cited by 31
Jin, D., Wang, F., Qu, L., Li, Z., Jin, L., Liu, P., Xu, X., & Cui, H. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0184-1 · Cited by 24
Szarmach, A., Halena, G., Kaszubowski, M. F., Piskunowicz, M., Studniarek, M., Lass, P., Szurowska, E., & Winklewski, P. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051008 · Cited by 21
Time-sequenced drug delivery approaches towards effective chemotherapeutic treatment of glioma
Li, M., Luo, Z. Y., Xia, Z., Shen, X., & Cai, K. (2017) · Materials Horizons · doi:10.1039/c7mh00342k · Cited by 19
Михайлович, Ч. С., Yokoyama, S., Mizuno, A., Ichinose, W., Lopatina, O. L., Shabalova, A. A., Salmina, A. B., Yamamoto, Y., Okamoto, H., Shuto, S., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.290 · Cited by 16
ANG1005: Results of a phase I study in patients with recurrent malignant glioma.
Drappatz, J., Brenner, A. J., Rosenfeld, S., Groves, M. D., Mikkelsen, T., Schiff, D., Sarantopoulos, J., Wong, E. T., Wen, P. Y., & Castaigne, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2009 · Cited by 13
Antibody-drug conjugates as drug carrier systems for bioactive agents
Akash, M. S. H., Rehman, K., Parveen, A., & Ibrahim, M. (2015) · International Journal of Polymeric Materials · doi:10.1080/00914037.2015.1038818 · Cited by 12
Circumventing the blood–brain barrier
Shen, H. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716187114 · Cited by 12
Cited by
The blood-brain barrier: Physiology and strategies for drug delivery
Pandit, R., Chen, L., & Götz, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.009 · Cited by 651
Barhoum, A., García-Betancourt, M. L., Jeevanandam, J., Hussien, E. A., Mekkawy, S. A., Mostafa, M., Omran, M. M., S. Abdalla, M., & Bechelany, M. (2022) · Nanomaterials · doi:10.3390/nano12020177 · Cited by 447
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Blood-Brain Delivery Methods Using Nanotechnology
Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040269 · Cited by 305
Norouzi, M., Yathindranath, V., Thliveris, J. A., Kopec, B. M., Siahaan, T. J., & Miller, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-68017-y · Cited by 292
Metadata
- Authors
- He, Q., Liu, J., Liang, J., Liu, X., Li, W., Liu, Z., Ding, Z., & Tuo, D.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2018-03-23
- Volume
- 7
- Issue
- 4
- Pages
- 24
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2792640679
- Cited by
- 298
- References
- 105
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.